EMA guidance on risk management plans for COVID-19 vaccines reviewed

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
News Item
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661824/
http://dx.doi.org/10.1007/s40278-020-85952-9
_version_ 1783609274960707584
collection PubMed
description
format Online
Article
Text
id pubmed-7661824
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-76618242020-11-13 EMA guidance on risk management plans for COVID-19 vaccines reviewed Reactions Weekly News Item Springer International Publishing 2020-11-14 2020 /pmc/articles/PMC7661824/ http://dx.doi.org/10.1007/s40278-020-85952-9 Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
EMA guidance on risk management plans for COVID-19 vaccines reviewed
title EMA guidance on risk management plans for COVID-19 vaccines reviewed
title_full EMA guidance on risk management plans for COVID-19 vaccines reviewed
title_fullStr EMA guidance on risk management plans for COVID-19 vaccines reviewed
title_full_unstemmed EMA guidance on risk management plans for COVID-19 vaccines reviewed
title_short EMA guidance on risk management plans for COVID-19 vaccines reviewed
title_sort ema guidance on risk management plans for covid-19 vaccines reviewed
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661824/
http://dx.doi.org/10.1007/s40278-020-85952-9

Ejemplares similares